Login / Signup

Pharmacokinetics, pharmacodynamics, and tolerability of an aqueous formulation of rusfertide (PTG-300), a hepcidin mimetic, in healthy volunteers: A double-blind first-in-human study.

Nishit B ModiRichard ShamesJason D LickliterSuneel Gupta
Published in: European journal of haematology (2024)
Rusfertide was well tolerated and showed dose-dependent pharmacokinetics and pharmacodynamics.
Keyphrases
  • endothelial cells
  • drug delivery
  • open label
  • randomized controlled trial
  • induced pluripotent stem cells
  • clinical trial
  • ionic liquid
  • pluripotent stem cells
  • double blind